// App-Quantinova.ai

EXTH-11 : TELOMERASE INHIBITION IS AN EFFECTIVE THERAPEUTIC STRATEGY IN TERT PROMOTER-MUTANT GLIOBLASTOMAS MODELS WITH LOW TUMOR BURDEN

Researchers

Presenter

  • Lauren Kageler

Principal Investigators

  • Elisa Aquilanti

  • Jacqueline Watson

  • Duncan Baird

  • Rhiannon Jones

  • Marie Hodges

  • Patrick Y Wen

  • Matthew Meyerson

Medical Centers

  • Dana-Farber Cancer Institute, BOSTON, MA, USA

  • Cardiff University, Cardiff, United Kingdom

  • Broad Institute, Cambridge, MA, USA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

  • Solid malignancies

Biomarkers

  • Telomerase reverse transcriptase

Drug/Treatment

  • Doxycycline

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved